| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2017/04/08 | 04 : 23 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/28 | 05 : 09 | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/28 | 00 : 30 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/22 | 01 : 19 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 06 : 54 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 06 : 51 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 06 : 48 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 06 : 46 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 06 : 44 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 06 : 41 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 06 : 40 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 06 : 38 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 06 : 37 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 06 : 14 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 04 : 19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 04 : 19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 04 : 19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 04 : 18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 04 : 18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 04 : 18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 04 : 17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 04 : 17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 04 : 17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 04 : 16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 04 : 16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 04 : 15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 04 : 15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/17 | 04 : 15 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/16 | 23 : 42 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 2017/02/16 | 23 : 15 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |